Compare EZPW & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EZPW | ARDX |
|---|---|---|
| Founded | 1989 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | 1996 | 2014 |
| Metric | EZPW | ARDX |
|---|---|---|
| Price | $29.97 | $6.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $30.67 | $15.14 |
| AVG Volume (30 Days) | 706.5K | ★ 3.2M |
| Earning Date | 04-27-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.09 | N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $747,954,000.00 | $2,607,000.00 |
| Revenue This Year | $25.48 | $37.75 |
| Revenue Next Year | $11.32 | $34.24 |
| P/E Ratio | $53.27 | ★ N/A |
| Revenue Growth | ★ 2.39 | N/A |
| 52 Week Low | $12.89 | $3.50 |
| 52 Week High | $29.99 | $8.40 |
| Indicator | EZPW | ARDX |
|---|---|---|
| Relative Strength Index (RSI) | 72.57 | 57.32 |
| Support Level | $24.39 | $5.49 |
| Resistance Level | N/A | $6.70 |
| Average True Range (ATR) | 0.97 | 0.23 |
| MACD | 0.31 | 0.09 |
| Stochastic Oscillator | 98.78 | 80.95 |
EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buys and sells second-hand goods. The operating segments of the company are U.S. Pawn, Latin America Pawn, and Other Investments. The U.S. Pawn segment includes all pawn activities in the United States. The Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales, which are mainly collateral forfeited from pawn lending operations and used merchandise purchased from the customers.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.